Rocamora, Edwin Z.
HRN: 29-08-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
CEFTAZIDIME 1GM (VIAL)
06/03/2026
06/09/2026
IV
2gm
Q8h
Sacral Ulcer
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes